A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. / Petersen, L J; Petersen, J R; Talleruphuus, U; Møller, M L; Ladefoged, S D; Mehlsen, J; Jensen, H A.

In: Clinical Nephrology, Vol. 55, No. 5, 01.05.2001, p. 375-83.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Petersen, LJ, Petersen, JR, Talleruphuus, U, Møller, ML, Ladefoged, SD, Mehlsen, J & Jensen, HA 2001, 'A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension', Clinical Nephrology, vol. 55, no. 5, pp. 375-83.

APA

Petersen, L. J., Petersen, J. R., Talleruphuus, U., Møller, M. L., Ladefoged, S. D., Mehlsen, J., & Jensen, H. A. (2001). A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. Clinical Nephrology, 55(5), 375-83.

Vancouver

Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J et al. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. Clinical Nephrology. 2001 May 1;55(5):375-83.

Author

Petersen, L J ; Petersen, J R ; Talleruphuus, U ; Møller, M L ; Ladefoged, S D ; Mehlsen, J ; Jensen, H A. / A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. In: Clinical Nephrology. 2001 ; Vol. 55, No. 5. pp. 375-83.

Bibtex

@article{e2c7896b1f28445cb65eecdf5bb203cb,
title = "A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension",
abstract = "Treatment of hypertension in patients with chronic renal failure has been shown to postpone the decline in renal function. Treatment with an ACE inhibitor has been shown to be superior to conventional antihypertensive treatment, but it is not known how an ACE inhibitor compares to treatment with a calcium channel blocker or to treatment with a combination of these drugs. The aim of the study was to evaluate the rate of decline in GFR in patients with chronic renal failure and hypertension treated with isradipine and spirapril as monotherapy and in combination.",
author = "Petersen, {L J} and Petersen, {J R} and U Talleruphuus and M{\o}ller, {M L} and Ladefoged, {S D} and J Mehlsen and Jensen, {H A}",
year = "2001",
month = may,
day = "1",
language = "English",
volume = "55",
pages = "375--83",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "5",

}

RIS

TY - JOUR

T1 - A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension

AU - Petersen, L J

AU - Petersen, J R

AU - Talleruphuus, U

AU - Møller, M L

AU - Ladefoged, S D

AU - Mehlsen, J

AU - Jensen, H A

PY - 2001/5/1

Y1 - 2001/5/1

N2 - Treatment of hypertension in patients with chronic renal failure has been shown to postpone the decline in renal function. Treatment with an ACE inhibitor has been shown to be superior to conventional antihypertensive treatment, but it is not known how an ACE inhibitor compares to treatment with a calcium channel blocker or to treatment with a combination of these drugs. The aim of the study was to evaluate the rate of decline in GFR in patients with chronic renal failure and hypertension treated with isradipine and spirapril as monotherapy and in combination.

AB - Treatment of hypertension in patients with chronic renal failure has been shown to postpone the decline in renal function. Treatment with an ACE inhibitor has been shown to be superior to conventional antihypertensive treatment, but it is not known how an ACE inhibitor compares to treatment with a calcium channel blocker or to treatment with a combination of these drugs. The aim of the study was to evaluate the rate of decline in GFR in patients with chronic renal failure and hypertension treated with isradipine and spirapril as monotherapy and in combination.

M3 - Journal article

VL - 55

SP - 375

EP - 383

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 5

ER -

ID: 34073870